EUVIMEDEUVIMED entdecken
Crossref

Interpatient and intrapatient variability in organ absorbed doses during [177Lu]Lu-DOTATATE therapy for neuroendocrine tumors

Malgorzata Poniatowska-Roszkowska iD, Hanna Piwowarska-Bilska iD, Mikołaj Roszkowski, Bożena Birkenfeld iD

Nuclear Medicine Review · 20.04.2026 · 29

DOI: 10.5603/nmr.114542 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nuclear Medicine Review, online erschienen am 20.04.2026. Verfasst von Malgorzata Poniatowska-Roszkowska und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, Pomeranian Medical University in Szczecin, Szczecin, Poland. M.poniatowska94@gmail.com. Hauptthemen laut MEDLINE: Neuroendocrine Tumors, Organometallic Compounds, Octreotide, Radiation Dosage.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neuroendocrine TumorsOrganometallic CompoundsOctreotideRadiation DosageAbsorption, RadiationHumansFemaleMaleRadiometryMiddle AgedRadiotherapy DosageAgedSingle Photon Emission Computed Tomography Computed Tomography

Stichwörter der Autor:innen

[177Lu]Lu-DOTATATEabsorbed doseindividualized dosimetryinterpatient variabilityneuroendocrine tumors

Substanzen

Organometallic Compoundslutetium Lu 177 dotatateOctreotide

Autor:innen und Institutionen

  • Department of Nuclear Medicine, Pomeranian Medical University in Szczecin, Szczecin, Poland. M.poniatowska94@gmail.com.
  • Department of Nuclear Medicine, Pomeranian Medical University in Szczecin, Szczecin, Poland.
  • Medical Artificial Intelligence Laboratory, Institute of Medical Sciences, University of Zielona Gora, Zielona Gora, Poland.

ORCID-Profile: Malgorzata Poniatowska-Roszkowska, Hanna Piwowarska-Bilska, Bożena Birkenfeld

Zitieren

APA

Poniatowska-Roszkowska, M., Piwowarska-Bilska, H., Roszkowski, M., & Birkenfeld, B. (2026). Interpatient and intrapatient variability in organ absorbed doses during [177Lu]Lu-DOTATATE therapy for neuroendocrine tumors. Nuclear Medicine Review, 29(0). https://doi.org/10.5603/nmr.114542

Vancouver

Poniatowska-Roszkowska M, Piwowarska-Bilska H, Roszkowski M, Birkenfeld B. Interpatient and intrapatient variability in organ absorbed doses during [177Lu]Lu-DOTATATE therapy for neuroendocrine tumors. Nuclear Medicine Review. 2026;29(0). doi:10.5603/nmr.114542

BibTeX
@article{PoniatowskaRoszkowska2026,
  author = {Poniatowska-Roszkowska, Malgorzata and Piwowarska-Bilska, Hanna and Roszkowski, Mikołaj and Birkenfeld, Bożena},
  title = {Interpatient and intrapatient variability in organ absorbed doses during [177Lu]Lu-DOTATATE therapy for neuroendocrine tumors},
  journal = {Nuclear Medicine Review},
  year = {2026},
  volume = {29},
  number = {0},
  doi = {10.5603/nmr.114542}
}
Kostenlos starten →